Exploration of critical parameters for transient retrovirus production

Anderson, 1998, Human gene therapy, Nature, 392, 25, 10.1038/32801

Gerin, 1999, Improved titers of retroviral vectors from the human FLYRD18 packaging cell line in serum- and protein-free medium, Hum. Gene Ther., 10, 1965, 10.1089/10430349950017329

Gerin, 1999, Production of retroviral vectors for gene therapy with the human packaging cell line FLYRD18, Biotechnol. Prog., 15, 941, 10.1021/bp990085b

Glimm, 1998, Efficient serum-free retroviral gene transfer into primitive human hematopoietic progenitor cells by a defined, high-titer, nonconcentrated vector-containing medium, Hum. Gene Ther., 9, 771, 10.1089/hum.1998.9.6-771

Kafri, 2001, Lentivirus vectors: difficulties and hopes before clinical trials, Curr. Opin. Mol. Ther., 3, 316

Kitajewski, 1986, An adenovirus mutant unable to express VAI RNA displays different growth responses and sensitivity to interferon in various host cell lines, Mol. Cell. Biol., 6, 4493, 10.1128/MCB.6.12.4493

Le Doux, 1996, Proteoglycans secreted by packaging cell lines inhibit retrovirus infection, J. Virol., 70, 6468, 10.1128/JVI.70.9.6468-6473.1996

Le Doux, 1998, Removal of proteoglycans increases efficiency of retroviral gene transfer, Biotechnol. Bioeng., 58, 23, 10.1002/(SICI)1097-0290(19980405)58:1<23::AID-BIT3>3.0.CO;2-W

Le Doux, 1999, Kinetics of retrovirus production and decay, Biotechnol. Bioeng., 63, 654, 10.1002/(SICI)1097-0290(19990620)63:6<654::AID-BIT3>3.0.CO;2-1

McTaggart, 2000, Effects of culture parameters on the production of retroviral vectors by a human packaging cell line, Biotechnol. Prog., 16, 859, 10.1021/bp000078j

Mountain, 2000, Gene therapy: the first decade, Trends Biotechnol., 18, 119, 10.1016/S0167-7799(99)01416-X

Naviaux, 1996, The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses, J. Virol., 70, 5701, 10.1128/JVI.70.8.5701-5705.1996

O'Malley, 1986, A mechanism for the control of protein synthesis by adenovirus VA RNAI, Cell, 44, 391, 10.1016/0092-8674(86)90460-5

Podsakoff, 2001, Lentiviral vectors approach the clinic but fall back: National Institutes of Health Recombinant DNA Advisory Committee review of a first clinical protocol for use of a lentiviral vector, Mol. Ther., 4, 282, 10.1006/mthe.2001.0470

Soneoka, 1995, A transient three-plasmid expression system for the production of high titer retroviral vectors, Nucleic Acids Res., 23, 628, 10.1093/nar/23.4.628

Yang, 1999, Generation of retroviral vector for clinical studies using transient transfection, Hum. Gene Ther., 10, 123, 10.1089/10430349950019255

Yap, 2000, Effects of stoichiometry of retroviral components on virus production, J. Gen. Virol., 81, 2195, 10.1099/0022-1317-81-9-2195